Literature DB >> 2312166

Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.

R Moqbel1, A J Macdonald, O Cromwell, A B Kay.   

Abstract

The release of leukotriene C4 (LTC4) from human low-density eosinophils following adherence to live or formalin-fixed schistosomula of Schistosoma mansoni coated with parasite-specific IgE or IgG obtained from pooled human anti-S. mansoni serum has been studied. IgE-rich fractions were obtained after fractionation of pooled immune sera on fast-protein liquid chromatography (FPLC; polyanion SI-17 column) and were identified by parasite-specific RAST. Contaminating IgG was removed by adsorption on a Staphylococcus aureus-protein A affinity column. IgG-rich FPLC fractions were identified by a specific ELISA assay. IgG-dependent activities were confirmed by protein A adsorption. Low-density eosinophils adhered to live and formalin-fixed schistosomula coated with specific antisera and released 11.7 +/- 2.7 and 16.5 +/- 3.5 pmoles of LTC4/10(6) cells, respectively. LTC4 release induced by A23187 (5 x 10(-6) M) from the same cells was 80 +/- 24 pmoles/10(6) cells and 9.9 +/- 1 pmoles/10(6) cells in the presence of Sepharose particles (CNBr-activated 4B beads) covalently coated with normal human IgG. Fixed schistosomula coated with FPLC-purified IgE and IgG gave 7.6 +/- 0.4 and 6.0 +/- 0.1 pmoles of LTC4 per 10(6) low-density eosinophils, respectively. The same IgE- and IgG-rich fractions induced eosinophil-mediated cytotoxicity of live schistosomula in vitro. Removal of IgE by an anti-IgE affinity column abolished both the IgE-dependent release of LTC4 and the in vitro killing of larvae. Conversely, IgG-dependent activities were abolished by protein A, but not anti-IgE, adsorption. Normal density eosinophils generated undetectable amounts of LTC4 when incubated with IgE-coated schistosomula, whereas with IgG-coated larvae 4.6 pmoles/10(6) cells were obtained. Following preincubation with platelet-activating factor (PAF) (10(-7) M) and leukotriene B4 (LTB4) (10(-7) M), normal density eosinophils released LTC4 when in contact with larvae coated with antigen-specific IgE. Lyso-PAF had no effect in any of the systems tested. The synthetic chemotactic tripeptide formyl-methionyl-leucyl-phenylalanine (FMLP) had no influence on IgE-dependent release of LTC4 from eosinophils. In contrast, FMLP (10(-7) M) enhanced the IgG-dependent LTC4 release, with PAF and LTB4 also showing a small enhancing effect. None of these agents substantially altered the release potential of low-density eosinophils in either IgE- or IgG-dependent events. Thus the results presented here indicate that in an IgE-dependent system, human low-density eosinophils can be induced to adhere to and kill IgE-coated helminthic targets and release biologically relevant amounts of LTC4.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312166      PMCID: PMC1385964     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  In vitro bioassay of sheep gastrointestinal mucus for nematode paralysing activity mediated by substances with some properties characteristic of SRS-A.

Authors:  P G Douch; G B Harrison; L L Buchanan; K S Greer
Journal:  Int J Parasitol       Date:  1983-04       Impact factor: 3.981

2.  Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.

Authors:  A R Anwar; J R McKean; S R Smithers; A B Kay
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

3.  The communication of ELISA data from laboratory to clinician.

Authors:  D de Savigny; A Voller
Journal:  J Immunoassay       Date:  1980

4.  Fc receptors for IgE on human and rat eosinophils.

Authors:  M Capron; A Capron; J P Dessaint; G Torpier; S G Johansson; L Prin
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

5.  Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products.

Authors:  W R Henderson; J B Harley; A S Fauci
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

6.  Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia.

Authors:  L Prin; M Capron; A B Tonnel; O Bletry; A Capron
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

7.  Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.

Authors:  L Nagy; T H Lee; E J Goetzl; W C Pickett; A B Kay
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

8.  Role of IgE receptors in effector function of human eosinophils.

Authors:  M Capron; H L Spiegelberg; L Prin; H Bennich; A E Butterworth; R J Pierce; M A Ouaissi; A Capron
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

9.  Altered density, metabolism and surface receptors of eosinophils in eosinophilia.

Authors:  I Winqvist; T Olofsson; I Olsson; A M Persson; T Hallberg
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

10.  Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4.

Authors:  R Moqbel; S P Sass-Kuhn; E J Goetzl; A B Kay
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

View more
  11 in total

1.  Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G.

Authors:  M H Shin; H Kita; H Y Park; J Y Seoh
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

3.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

Review 4.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 5.  Eosinophil-mediated tissue inflammatory responses in helminth infection.

Authors:  Myeong Heon Shin; Young Ah Lee; Duk-Young Min
Journal:  Korean J Parasitol       Date:  2009-10       Impact factor: 1.341

Review 6.  Eosinophil IgE receptor and CD23.

Authors:  M Capron; M J Truong; D Aldebert; V Gruart; M Suemura; G Delespesse; B Tourvieille; A Capron
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 7.  Expression, regulation and function of human Fc epsilon RII (CD23) antigen.

Authors:  M Sarfati; S Fournier; C Y Wu; G Delespesse
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

8.  The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils.

Authors:  R Moqbel; G M Walsh; T Nagakura; A J MacDonald; A J Wardlaw; Y Iikura; A B Kay
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

9.  Investigations into the production and function of leukotrienes during histotropic development of Oesophagostomum dentatum.

Authors:  A Daugschies
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

10.  Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes.

Authors:  Geoffrey N Gobert; Mai H Tran; Luke Moertel; Jason Mulvenna; Malcolm K Jones; Donald P McManus; Alex Loukas
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.